Ortho Medical Diagnostics (Ortho), a world chief of in vitro diagnostics, and EKF Diagnostics (EKF) at this time introduced an settlement that enables Ortho prospects to entry to Beta-Hydroxybutyrate (BHB) assay, an essential marker used along side scientific findings and different lab exams for the prognosis and administration of ketoacidosis and its primary causative issue, diabetic ketoacidosis (DKA).
The high-quality, absolutely automated assay is now obtainable to be used on Ortho’s VITROS® 4600 Chemistry System and the VITROS® 5600 Built-in System.
Diabetic ketoacidosis is a critical complication that may result in a disruption of chemical stability within the physique, and might be deadly if left undiagnosed. EKF’s enzymatic Beta-Hydroxybutyrate (BHB) assay is used primarily for figuring out each the presence and diploma of ketosis in suspected diabetic ketoacidosis circumstances.
The BHB assay produces a quantitative worth that’s particular to the BHB ‘ketone physique’. These qualities make the BHB assay the brand new scientific diagnostic customary of look after ketone testing.
“Ortho is dedicated to delivering a broad menu of assays to our prospects within the scientific lab, whether or not by in-house growth or collaborations just like the one with EKF,” mentioned Ortho’s chief Working Officer Robert Yates.
Ortho and EKF are collaborating to offer the BHB assay as a validated MicroTip Partnership Assay (MPA) software within the U.S. and Canada. This MPA makes use of the Person Outlined Assay (UDA) function, which gives the aptitude to program assay parameters as outlined within the EKF- Stanbio Assay Utility Sheet.
The Beta-Hydroxybutyrate LiquiColor® assay has been CLIA labeled by the U.S. Meals and Drug Administration (FDA) as a MODERATE complexity assay on the VITROS® 4600 Chemistry System and VITROS® 5600 Built-in System.
“Diabetic ketoacidosis is a critical situation, and our collaboration with Ortho Medical Diagnostics will assist to ship the essential BHB assay to their present prospects” mentioned EKF’s Diagnostics Head of Gross sales, Gilbert Mejia.
EKF Diagnostics’ Stanbio Chemistry portfolio is a broad vary of liquid-stable reagents, calibrators, requirements and controls. LiquiColor® and Liqui-UV® reagents are designed for optimum stability, ease-of-use and are optimized for at this time’s chemistry analyzers. Along with its BHB check for ketosis, EKF continues to construct on its profitable vary of esoteric reagents.